Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression
RecruitingNCT05798143Phase: NAStarted 2023-02-28
Summary
Background: 30-50% of patients with Major Depressive Disorder (MDD) do not respond adequately despite two or more antidepressant treatments with proper dosage and timing of administration, configuring
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
ITABChieti, Italy
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05798143